These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 9649916

  • 1. Oral contraceptive use before and after the latest pill scare in The Netherlands. Changes in oral contraceptive use and how users change.
    de Vries CS, van den Berg PB, de Jong-van den Berg LT.
    Contraception; 1998 Apr; 57(4):247-9. PubMed ID: 9649916
    [Abstract] [Full Text] [Related]

  • 2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.
    Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419
    [Abstract] [Full Text] [Related]

  • 3. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP.
    Lancet; 1995 Dec 16; 346(8990):1593-6. PubMed ID: 7500751
    [Abstract] [Full Text] [Related]

  • 4. Effect of the British warning on contraceptive use in the General Medical Service in Ireland.
    Williams D, Kelly A, Carvalho M, Feely J.
    Ir Med J; 1998 Dec 16; 91(6):202-3. PubMed ID: 10069128
    [Abstract] [Full Text] [Related]

  • 5. The 1995 pill scare revisited: anatomy of a non-epidemic.
    Spitzer WO.
    Hum Reprod; 1997 Nov 16; 12(11):2347-57. PubMed ID: 9436662
    [Abstract] [Full Text] [Related]

  • 6. Impact of the October 1995 pill scare in Grampian.
    Flett G, Gurney E, McKessock L, Reid J.
    Br J Fam Plann; 1998 Apr 16; 24(1):18-20. PubMed ID: 9719702
    [Abstract] [Full Text] [Related]

  • 7. The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.
    Farmer RD, Todd JC, Lewis MA, MacRae KD, Williams TJ.
    Contraception; 1998 Feb 16; 57(2):67-70. PubMed ID: 9589831
    [Abstract] [Full Text] [Related]

  • 8. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
    Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L.
    Contraception; 1997 Sep 16; 56(3):141-6. PubMed ID: 9347203
    [Abstract] [Full Text] [Related]

  • 9. The impact of the October 1995 'pill scare' on oral contraceptive use in the United Kingdom: analysis of a general practice automated database.
    Martin RM, Hilton SR, Kerry SM.
    Fam Pract; 1997 Aug 16; 14(4):279-84. PubMed ID: 9283846
    [Abstract] [Full Text] [Related]

  • 10. Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third-generation oral contraceptives.
    Skjeldestad FE.
    Contraception; 1997 Jan 16; 55(1):11-4. PubMed ID: 9013055
    [Abstract] [Full Text] [Related]

  • 11. Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.
    Farmer RD, Lawrenson RA.
    Am J Obstet Gynecol; 1998 Sep 16; 179(3 Pt 2):S78-86. PubMed ID: 9753314
    [Abstract] [Full Text] [Related]

  • 12. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R.
    Contraception; 1997 Sep 16; 56(3):129-40. PubMed ID: 9347202
    [Abstract] [Full Text] [Related]

  • 13. Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens.
    van Lunsen HW.
    Eur J Contracept Reprod Health Care; 1996 Sep 16; 1(1):39-45. PubMed ID: 9678136
    [Abstract] [Full Text] [Related]

  • 14. Another pill scare -- should we audit its impact?
    Bromham DR.
    Audit Unit News; 1996 Jan 16; 1(4):2-3. PubMed ID: 12346948
    [Abstract] [Full Text] [Related]

  • 15. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.
    Farmer RD, Williams TJ, Simpson EL, Nightingale AL.
    BMJ; 1996 Jan 16; 321(7259):477-9. PubMed ID: 10948026
    [Abstract] [Full Text] [Related]

  • 16. Coagulation and anticoagulation effects of contraceptive steroids.
    Samsioe G.
    Am J Obstet Gynecol; 1994 May 16; 170(5 Pt 2):1523-7. PubMed ID: 8178901
    [Abstract] [Full Text] [Related]

  • 17. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
    Heinemann LA, Lewis MA, Thorogood M, Spitzer WO, Guggenmoos-Holzmann I, Bruppacher R.
    BMJ; 1997 Dec 06; 315(7121):1502-4. PubMed ID: 9420491
    [Abstract] [Full Text] [Related]

  • 18. Bias versus causality: interpreting recent evidence of oral contraceptive studies.
    Spitzer WO.
    Am J Obstet Gynecol; 1998 Sep 06; 179(3 Pt 2):S43-50. PubMed ID: 9753310
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E, Malone KE, Weiss NS, Daling JR.
    J Natl Cancer Inst; 1994 Apr 06; 86(7):505-14. PubMed ID: 8133534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.